lobbying_activities: 2820561

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2820561	77823c84-28ae-4857-99fc-de57e37ede8b	Q2	GOVERNMENT COUNSEL, LLC	401105070	APOTEX CORPORATION	2022	second_quarter	MAN	Monitoring issues relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2022-07-15T13:15:57-04:00